MAP2K1 and Langerhans cell histiocytosis: In our previous study, the overall percentage of BRAF and MAP2K1 mutations detected through target gene sequencing of overall adult LCH patients was nearly 90% [7], but it was 59.3% in unifocal LCH patients in adults.